Annual Long Term Debt
$19.85 M
-$498.00 K-2.45%
31 December 2023
Summary:
Adaptimmune Therapeutics annual long term debt is currently $19.85 million, with the most recent change of -$498.00 thousand (-2.45%) on 31 December 2023. During the last 3 years, it has fallen by -$1.09 million (-5.19%). ADAP annual long term debt is now -14.24% below its all-time high of $23.15 million, reached on 31 December 2021.ADAP Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$70.32 M
+$28.27 M+67.21%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly long term debt is currently $70.32 million, with the most recent change of +$28.27 million (+67.21%) on 30 September 2024. Over the past year, it has increased by +$49.80 million (+242.69%). ADAP quarterly long term debt is now at all-time high.ADAP Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.5% | +242.7% |
| 3 y3 years | -5.2% | +196.7% |
| 5 y5 years | +100.0% | +211.2% |
ADAP Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.2% | at low | at high | +281.3% |
| 5 y | 5 years | -14.2% | at high | +281.3% | |
| alltime | all time | -14.2% | at high |
Adaptimmune Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $70.32 M(+67.2%) |
| June 2024 | - | $42.05 M(+128.0%) |
| Mar 2024 | - | $18.44 M(-7.1%) |
| Dec 2023 | $19.85 M(-2.4%) | $19.85 M(-3.3%) |
| Sept 2023 | - | $20.52 M(-5.0%) |
| June 2023 | - | $21.59 M(+8.0%) |
| Mar 2023 | - | $19.99 M(-1.8%) |
| Dec 2022 | $20.35 M(-12.1%) | $20.35 M(+2.1%) |
| Sept 2022 | - | $19.93 M(-7.9%) |
| June 2022 | - | $21.64 M(-6.8%) |
| Mar 2022 | - | $23.22 M(+0.3%) |
| Dec 2021 | $23.15 M | $23.15 M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $23.70 M(+20.2%) |
| June 2021 | - | $19.72 M(-0.9%) |
| Mar 2021 | - | $19.90 M(-5.0%) |
| Dec 2020 | $20.94 M(-8.8%) | $20.94 M(-0.7%) |
| Sept 2020 | - | $21.09 M(+1.3%) |
| June 2020 | - | $20.81 M(-4.6%) |
| Mar 2020 | - | $21.83 M(-5.0%) |
| Dec 2019 | $22.97 M(>+9900.0%) | $22.97 M(+1.6%) |
| Sept 2019 | - | $22.60 M(-4.5%) |
| June 2019 | - | $23.67 M(-11.6%) |
| Mar 2019 | - | $26.78 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Adaptimmune Therapeutics annual long term debt?
- What is the all time high annual long term debt for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual long term debt year-on-year change?
- What is Adaptimmune Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly long term debt year-on-year change?
What is Adaptimmune Therapeutics annual long term debt?
The current annual long term debt of ADAP is $19.85 M
What is the all time high annual long term debt for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual long term debt is $23.15 M
What is Adaptimmune Therapeutics annual long term debt year-on-year change?
Over the past year, ADAP annual long term debt has changed by -$498.00 K (-2.45%)
What is Adaptimmune Therapeutics quarterly long term debt?
The current quarterly long term debt of ADAP is $70.32 M
What is the all time high quarterly long term debt for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly long term debt is $70.32 M
What is Adaptimmune Therapeutics quarterly long term debt year-on-year change?
Over the past year, ADAP quarterly long term debt has changed by +$49.80 M (+242.69%)